anonymous
Guest
anonymous
Guest
Everyone came over here to Dermavant!
The new Galdermavant.
The new Galdermavant.
Everyone came over here to Dermavant!
The new Galdermavant.
Define “everyone”. So far, anyone who has left is no one notable. Reps who weren’t doing well here so jumped ship.
Finally someone who gets it! It‘s all about biologics. Topicals are PCP generics nowadays. Any company without biologics is heading for extinction.Another topical…it’s all about biologics and small molecules now. Out with the old in with the new. Same old leadership same old headaches!
Finally someone who gets it! It‘s all about biologics. Topicals are PCP generics nowadays. Any company without biologics is heading for extinction.
If you think you can go from Galderma to Amgen or even BMS then good luck with that. Most of us have seen interest from derm only companies like Dermavant.
Dermavant wont last long. Car salesman leadership mentality with micromanagers for managers. I’d bet anything 12 months until sell off post launch of another me too topical. Amgen is the place to be!
Galderma is a nobody in pharma. Going to Amgen, BMS, Sanofi and other big players is very, very difficult.If you think you can go from Galderma to Amgen or even BMS then good luck with that. Most of us have seen interest from derm only companies like Dermavant.
Dear Loser,. There's always a first topical to be a billion dollar RX and Tapinarof will be just that. It will happen after the AD approval. When it does all of us will be making more $ than you will know. Hold your negative comments for a few months. Good Evening!
Galderma? Who are they? What do they do? Hahahaha!!!Galderma is a nobody in pharma. Going to Amgen, BMS, Sanofi and other big players is very, very difficult.